Vanguard Capital Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $768K | Buy |
4,139
+449
| +12% | +$83.3K | 0.76% | 30 |
|
2025
Q1 | $773K | Hold |
3,690
| – | – | 0.95% | 24 |
|
2024
Q4 | $656K | Sell |
3,690
-23
| -0.6% | -$4.09K | 0.71% | 29 |
|
2024
Q3 | $733K | Sell |
3,713
-638
| -15% | -$126K | 0.77% | 28 |
|
2024
Q2 | $746K | Sell |
4,351
-64
| -1% | -$11K | 0.5% | 40 |
|
2024
Q1 | $804K | Buy |
4,415
+6
| +0.1% | +$1.09K | 0.57% | 39 |
|
2023
Q4 | $683K | Buy |
4,409
+89
| +2% | +$13.8K | 0.55% | 36 |
|
2023
Q3 | $644K | Sell |
4,320
-118
| -3% | -$17.6K | 0.6% | 40 |
|
2023
Q2 | $598K | Sell |
4,438
-194
| -4% | -$26.1K | 0.54% | 41 |
|
2023
Q1 | $738K | Sell |
4,632
-101
| -2% | -$16.1K | 0.74% | 33 |
|
2022
Q4 | $765K | Sell |
4,733
-27
| -0.6% | -$4.36K | 0.89% | 27 |
|
2022
Q3 | $639K | Sell |
4,760
-197
| -4% | -$26.4K | 0.78% | 32 |
|
2022
Q2 | $759K | Sell |
4,957
-1,580
| -24% | -$242K | 0.86% | 27 |
|
2022
Q1 | $1.06M | Buy |
6,537
+1,605
| +33% | +$260K | 0.76% | 34 |
|
2021
Q4 | $667K | Buy |
4,932
+54
| +1% | +$7.3K | 0.48% | 53 |
|
2021
Q3 | $526 | Sell |
4,878
-545
| -10% | -$59 | 0.35% | 69 |
|
2021
Q2 | $610K | Buy |
5,423
+190
| +4% | +$21.4K | 0.46% | 58 |
|
2021
Q1 | $551K | Sell |
5,233
-117
| -2% | -$12.3K | 0.47% | 52 |
|
2020
Q4 | $563K | Buy |
+5,350
| New | +$563K | 0.52% | 51 |
|
2020
Q2 | $489K | Buy |
+4,986
| New | +$489K | 0.57% | 46 |
|
2019
Q4 | $366K | Sell |
4,135
-1,040
| -20% | -$92.1K | 0.38% | 78 |
|
2019
Q3 | $391K | Buy |
+5,175
| New | +$391K | 0.46% | 66 |
|